Fifty-one isolates (25%) also had gyrA mutations and/or qnr genes, conferring resistance to fluoroquinolones, which in addition to the presence of beta-lactamases, indicates the potential compromised ability to treat animals with infections caused by these bacteria [53, 54]. This evidence concerns the gene LACTB and infection.